Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07065877Not yet recruiting
Randomised trial of cholecalciferol cream (2 arms), sponsored by Suez Canal University. Primary endpoints: Loss of crestal bone assessed clinically at 6 months, Stability of implant at 6 months and 1 more. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07065877.